Influence of the OATP1B1 and OATP1B3 Genotype on the Hepatic Uptake of Primovist®

NCT01420211 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Pharmacokinetics
MRI
Liver
Drug Transporter
Gd-EOB-DTPA

Interventions

DRUG: Primovist® 0,25 mmol/ml solution for injection
DEVICE: MRI

Sponsor

University Medicine Greifswald